Economic Evaluation of Epilepsy Treatment: A Review of the Literature
- 1 April 2002
- Vol. 43 (s4), 10-16
- https://doi.org/10.1046/j.1528-1157.43.s.4.3.x
Abstract
Summary: This article provides an overview of methods used and findings from economic analyses in epilepsy. Cost‐effectiveness studies have evaluated different drugs for monotherapy and add‐on therapy, and compared alternative treatment modalities for refractory epilepsy. The methodological characteristics of these studies are examined, and their results are compared and interpreted. Health outcome measures are defined and data sources described. Methods for assessing the direct and indirect costs, and/or cost savings, with a treatment's use, are explored. Directions for future research are identified and discussed.Keywords
This publication has 22 references indexed in Scilit:
- Economic analysis of epilepsy treatment: a cost minimization analysis comparing carbamazepine and lamotrigine in the UKSeizure, 1998
- New drugs for epilepsyCurrent Opinion in Neurology, 1998
- Commission on Outcome Measurement in Epilepsy, 1994–1997: Final ReportEpilepsia, 1998
- Ensuring Appropriate Care in EpilepsyDisease Management and Health Outcomes, 1998
- A cost-effectiveness analysis of anterior temporal lobectomy for intractable temporal lobe epilepsyJournal of Neurosurgery, 1997
- A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsyEpilepsy Research, 1997
- Cost‐Effectiveness of Anterotemporal Lobectomy in Medically Intractable Complex Partial EpilepsyEpilepsia, 1997
- A cost minimization study comparing vigabatrin, lamotrigine and gabapentin for the treatment of intractable partial epilepsySeizure, 1996
- The friction cost method for measuring indirect costs of diseaseJournal of Health Economics, 1995
- The Valuation of Human CapitalJournal of Political Economy, 1961